Naif Khalaf Alharbi - Concepedia

Author

Naif Khalaf Alharbi

King Abdullah International Medical Research Center ORCID

Also Known As

ALHARBI, NAIF, Alharbi, Naif, Alharbi, Naif K., Khalid Said Al Harthi, Muslim Younis Abuhasan, N Al-Harbi, N. AL-HARBI, Nadaa Alharbi, Naif Al-Harbi, Naif Alharbi

102

Publications

Citations

H-Index

Concepts

All Affiliations

King Abdullah International Medical Research Center King Saud bin Abdulaziz University for Health Sciences National Guard Health Affairs King Abdulaziz University University of Oxford

About

Naif Khalaf Alharbi is an author at King Abdullah International Medical Research Center specializing in medicine, covid-19, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	280
2	Public Health	4	4	120
3	Epidemiology	4	4	131
4	Cell Biology	2	2	65
5	Cellular Physiology	1	1	50

Naif Khalaf Alharbi

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice Naif Khalaf Alharbi, Eriko Padron-Regalado, Craig Thompson, Vaccine	2017	162
Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever George M. Warimwe, Joseph Gesharisha, B. Veronica Carr, Scientific Reports	2016	110
Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial Mohammad Bosaeed, Ahmad M. Alharbi, Ebrahim Mahmoud, Clinical Microbiology and Infection	2022	100
Humoral Immunogenicity and Efficacy of a Single Dose of ChAdOx1 MERS Vaccine Candidate in Dromedary Camels Naif Khalaf Alharbi, Ibrahim Qasim, Abdulrahman Almasoud, Scientific Reports	2019	89
Interferon Beta-1b and Lopinavir–Ritonavir for Middle East Respiratory Syndrome Yaseen M. Arabi, Ayed Y. Asiri, Abdullah M. Assiri, New England Journal of Medicine	2020	78
A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model Anwar M. Hashem, Abdullah Algaissi, Anurodh Shankar Agrawal, The Journal of Infectious Diseases	2019	74
Seroprevalence of SARS-CoV-2 (COVID-19) among healthcare workers in Saudi Arabia: comparing case and control hospitals Haleema Alserehi, Ada Alqunaibet, Jaffar A. Al‐Tawfiq, Diagnostic Microbiology and Infectious Disease Virus EpidemiologySaudi ArabiaMedicineCovid-19 PandemicInfection Control	2020	74
Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients Anwar M. Hashem, Abdullah Algaissi, Sarah A. Almahboub, Viruses VaccinationCoronavirus Disease 2019Disease SeverityHumoral ResponseViral Pathogenesis	2020	55
Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells Ahmed Bakillah, Fatimah Al Hejji, Abdulrahman Almasaud, Nutrients ImmunologyViral PathogenesisSars-cov-2 EntryLipid MovementViral Structural Protein	2022	50
Early Prediction of COVID-19 Ventilation Requirement and Mortality from Routinely Collected Baseline Chest Radiographs, Laboratory, and Clinical Data with Machine Learning Abdulrhman Aljouie, Ahmed Almazroa, Yahya Bokhari, Journal of Multidisciplinary Healthcare	2021	44

Page 1